TGFB1 and cancer: - Cancer-associated Fibroblasts (CAFs) drive T-effector cell inhibitory forces: Stiffening of ECM, secretion of inhibitory cytokines (TGF-β).- Suppressive cancer-associated macrophages (e.g., M2 type) and their products/ICI ligands also block CD8+ T-effector activity.